[시장보고서]세계의 표면 살균제 시장(2023-2030년)

세계의 표면 살균제 시장(2023-2030년)

Global Surface Disinfectants Market - 2023-2030

상품코드 : 1304549

리서치사 : DataM Intelligence

발행일 : 2023년 07월

페이지 정보 : 영문 195 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,350

￦ 6,069,000

PDF & Excel (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,850

￦ 6,767,000

PDF & Excel (Multiple User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,850

￦ 10,953,000

PDF & Excel (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

시장 개요

세계 표면 살균제 시장은 2022년 31억 달러에 달하고, 2030년에는 57억 달러에 달할 것으로 예상됩니다. 세계 표면 살균제 시장은 2023-2030년 예측 기간 동안 8.1%의 CAGR을 보일 것으로 예상됩니다.

병원 관련 감염 사례 증가, 제품 출시 증가, 새로운 소독제 도입, 정부의 노력, 살균에 대한 인식 증가 등은 예측 기간 동안 표면 살균제 세계 시장 성장을 촉진할 것으로 예상되는 요인 중 일부입니다.

시장 역학

입원 환자 수 증가로 표면 살균제 시장 성장 견인

입원 환자 수의 증가로 인해 표면 소독의 필요성이 증가함에 따라 예측 기간 동안 표면 소독제 시장의 세계 성장을 촉진할 것으로 예상됩니다. 예를 들어, 미국 보건 협회의 2022년 데이터에 따르면 2022년 입원 환자 수는 약 33,356,853명이었습니다. 이러한 입원의 대부분은 만성 질환 및 심장 우회 수술과 같은 중요한 시술로 인한 것입니다.

정부의 자금 지원 증가는 세계 표면 살균제 시장에 성장 기회를 가져다 줄 것으로 예상

보건 의료 시스템을 강화하기 위한 정부의 자금 지원 증가는 세계 표면 살균제 시장에 유망한 성장 기회를 제공할 것으로 추정됩니다. 예를 들어, 인도 정부는 자국 내 의료 인프라를 확장하기 위해 5,000억 루피(68억 달러) 상당의 신용 장려 프로그램을 제시할 준비를 하고 있습니다.

엄격한 규제기관의 존재가 예측 기간 동안 세계 표면 살균제 시장의 걸림돌로 작용할 것으로 예상

새롭게 개발된 표면 소독제 승인에 대한 엄격한 규제 기관의 존재는 예측 기간 동안 세계 시장 성장을 저해하는 요인입니다. 예를 들어, 소독제 등록 서비스는 중앙의약품표준관리기구(CDSCO)의 의약품 및 화장품법에 따라 관리되고 있으며, 소독제를 등록하려면 의약품과 관련된 모든 조례를 준수해야 합니다.

COVID-19 영향 분석

COVID-19 팬데믹과 전 세계 각국의 봉쇄로 인해 모든 산업 분야의 기업 재무 건전성이 영향을 받고 있습니다. 이에 미국 식품의약국(FDA)은 COVID-19 공중보건 비상사태 기간 동안 임상시험 참여자의 안전을 보장하고 임상시험의 무결성 위험을 최소화하기 위한 일반적인 고려사항을 포함한 가이드라인을 발표하여 임상시험 의뢰자와 연구자를 지원하고 임상시험의 안전과 우수 임상시험 관리기준(GCP)을 준수할 수 있도록 했습니다.

러시아-우크라이나 분쟁 영향 분석

러시아-우크라이나 분쟁은 스포츠 부상 발생률이 낮고 이 지역의 주요 시장 기업가 부족하기 때문에 세계 표면 살균제 시장에 중간 정도의 영향을 미칠 것으로 보입니다. 우크라이나의 진료소는 러시아 군대의 침략을 계속 견디고 있으며, 사망자 수 증가와 제한된 의료 지원에 쫓기고 있습니다. 의약품은 모든 제품이 부족합니다. 이 역시 기초 재료의 수입과 수출의 중요성이 예측 기간 동안 세계 표면 살균제 시장의 성장에 약간의 영향을 미칠 것으로 예상됩니다.

영문목차

Market Overview

The Global Surface Disinfectants Market reached US$ 3.1 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 5.7 billion by 2030. The global Surface Disinfectants market is expected to exhibit a CAGR of 8.1% during the forecast period 2023-2030.

The increase in the number of hospital-associated infection cases, rising product launches, introductions of new disinfectant chemicals, government initiatives, and increasing awareness about sanitization are among the factors expected to boost the global surface disinfectants market growth in the forecast period.

Market Dynamics

Increasing Number Of Hospital Admission Drive The Growth Of The Surface Disinfectants Market.

The increasing number of hospital admission are leading to an increased requirement for surface disinfection is expected to boost the global surface disinfectant market growth in the forecast period. For instance, according to 2022 data from the American Health Association, there were roughly 33,356,853 hospital admissions in 2022. Many of these admissions were due to chronic diseases and critical procedures like heart bypass surgery.

The Increasing Funding From The Government Is Expected To Present The Global Surface Disinfectants Market With Growth Opportunities.

The increasing funding from the government to boost the healthcare system is estimated to present the global surface disinfectant market with prospective growth opportunities. For instance, the Indian government is preparing to present a credit incentive program worth Rs. 500 billion (US$ 6.8 billion) to expand the country's healthcare infrastructure.

The Presence of Stringent Regulatory Bodies is Estimated To Hamper The Global Surface Disinfectants Market During The Forecast Period.

The presence of stringent regulatory bodies for the approval of newly developed surface disinfectants is hampering the global market growth in the forecast period. For instance, the disinfectant registration services are controlled under Drug and Cosmetics Act by The Central Drugs Standard Control Organisation (CDSCO) and all ordinances relevant to drugs are required to be obeyed for enlisting disinfectants.

COVID-19 Impact Analysis.

The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.

Russia-Ukraine War Impact Analysis.

The Russia-Ukraine conflict is thought to hold a moderate influence on the global Surface Disinfectants market, as there is a low incidence of sports injuries and a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all products of medications. Again, the significance of the import and export of fundamental materials are expected to slightly impact the global surface disinfectants market growth in the forecast period.

Segment Analysis

The Global Surface Disinfectants Market is segmented based on product, formulation, end-user, and region.

The Hospital End-User Segment is Estimated to Dominate the Global Surface Disinfectants Market.

With the increasing growth in the number of hospitals, the hospital end-user segment is estimated to hold about 38.5% of the global market by 2030. For instance, India is home to more than 69,000 public and private hospitals, comprising nearly 1.8 million beds. The country provides free healthcare services through its public health system governed independently by individual states and union territories.

Geographical Analysis

Europe is Estimated to Hold 27.7% of the Market Share Owing to the Growing Cases of Chronic Conditions in this Region.

Owing to the increased healthcare expenditure and utilization the European surface disinfectant market is estimated to hold about 27.7% of the global market share. For instance, according to the EuStats, there were more than 8,670 hospital discharges per 100,000 inhabitants in Albania in 2021, the most inferior percentage of in-patient discharges comparable to inhabitants proportions in the region, it was 4 % down corresponded to 2011.

Kosovo registered more than 8,815 hospital discharges per 100 000 inhabitants in 2021. In 2021 public expenditure on health in the EU was assessed at 8.8 % of GDP, while whole expenditure amounted to 10.9 %. This stood more elevated than in all the Western Balkans and Turkiye. In 2021, expenditure on health and the percentage of public health expenditure grew by 0.9% points each corresponding to 2011.

Competitive Landscape

The major global players in the market include: Procter & Gamble, Reckitt Benckiser Group plc., Carroll Company, Cantel Medical Corporation, UPS Hygiene Pvt. Ltd., Metrex Research, LLC., STERIS plc., Whiteley Corporation, PURE Bioscience, Inc. and Henkel AG, among others.

Why Purchase the Report?

To visualize the Global Surface Disinfectants Market segmentation based on product, formulation, end-user, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous surface disinfectant market-level data points with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available in Excel consisting of key products of all the major players.

The Global Surface Disinfectants Market Report Would Provide Approximately 53 Tables, 54 Figures And 195 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Industry Analysis

3.1. Porter's 5 Forces Analysis
3.2. Supply Chain Analysis
3.3. Pricing Analysis
3.4. Regulatory Analysis

4. Executive Summary

4.1. Snippet by Product
4.2. Snippet by Formulation
4.3. Snippet by End User
4.4. Snippet by Region

5. Dynamics

5.1. Impacting Factors
- 5.1.1. Drivers
  - 5.1.1.1. Increasing Market Developments
  - 5.1.1.2. Growing Cases of Hospital-Acquired Infections
- 5.1.2. Restraints
  - 5.1.2.1. Stringent Regulatory Authorities
- 5.1.3. Opportunity
  - 5.1.3.1. Increasing Awareness
- 5.1.4. Impact Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID-19
- 6.1.2. Scenario During COVID-19
- 6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Quaternary Ammonium Compounds (QACs) *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Peracetic Acid
7.4. Hydrogen Peroxide
7.5. Phenol
7.6. Alcohol
7.7. Sodium Hypochlorite
7.8. Hypochlorite
7.9. Others

8. By Formulation

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
- 8.1.2. Market Attractiveness Index, By Formulation
8.2. Wipes *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Sprays
8.4. Liquids

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals & Clinics *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Outpatient Surgical Centers
9.4. Restaurants & Food Chains
9.5. Households
9.6. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. The U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. The U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Spain
  - 10.3.6.5. Italy
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan

Australia

10.5.6.4. Rest of Asia-Pacific

10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Formulation
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Procter & Gamble *
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Reckitt Benckiser Group plc.
12.3. Carroll Company
12.4. Cantel Medical Corporation
12.5. UPS Hygiene Pvt. Ltd.
12.6. Metrex Research, LLC.
12.7. STERIS plc.
12.8. Whiteley Corporation
12.9. PURE Bioscience, Inc.
12.10. Henkel AG

LIST NOT EXHAUSTIVE

13. Appendix

13.1. About Us and Services
13.2. Contact Us